GW Pharmaceuticals plc (GWPH) Tops Q3 Loss Expectations

GW Pharmaceuticals plc (NASDAQ: GWPH) reported Q3 EPS of $0.06, $1.14 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $13 million versus the consensus estimate of $12.88 million.

For earnings history and earnings-related data on GW Pharmaceuticals plc (GWPH) click here.

You May Also Be Interested In

• Norwegian Cruise Line rating cut at Mizuho after 'self-inflicted wounds'
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business
• Evogene (EVGN) Tops Q2 EPS by 15c